Edgewise Therapeutics Inc...
(EWTX)
undefined
undefined%
At close: undefined
28.75
4.13%
After-hours Dec 13, 2024, 05:58 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | - | - | - | - | - |
Cost of Revenue | 1.73M | 538.00K | 272.00K | 185.00K | 123.00K |
Gross Profit | -1.73M | -538.00K | -272.00K | -185.00K | -123.00K |
Operating Income | -114.36M | -22.08M | -43.22M | -17.19M | -9.92M |
Interest Income | 14.19M | 2.66M | 402.00K | 69.00K | 219.00K |
Pretax Income | -100.16M | -19.41M | -42.81M | -17.12M | -9.71M |
Net Income | -100.16M | -15.40M | -42.14M | -17.05M | -9.49M |
Selling & General & Admin | 23.45M | 5.47M | 11.03M | 2.21M | 1.30M |
Research & Development | 90.91M | 16.61M | 32.19M | 14.98M | 8.62M |
Other Expenses | - | - | - | - | - |
Operating Expenses | 114.36M | 22.08M | 43.22M | 17.19M | 9.92M |
Interest Expense | - | 4.02M | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - |
Cost & Expenses | 114.36M | 22.08M | 43.22M | 17.19M | 9.92M |
Income Tax | - | -4.02M | -674.00K | -69.00K | -219.00K |
Shares Outstanding (Basic) | 63.72M | 53.59M | 49.50M | 49.22M | 49.22M |
Shares Outstanding (Diluted) | 63.72M | 53.59M | 49.50M | 49.22M | 49.22M |
EPS (Basic) | -1.57 | -0.29 | -0.85 | -0.35 | -0.19 |
EPS (Diluted) | -1.57 | -0.29 | -0.85 | -0.35 | -0.19 |
EBITDA | -112.81M | -67.10M | -42.94M | -17.01M | -9.80M |
Depreciation & Amortization | 1.73M | 538.00K | 272.00K | 185.00K | 123.00K |